OM
RETA

Opaleye Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Opaleye Management’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-183,750
Closed -$5.58M – 52
2022
Q2 		$5.58M Sell
183,750
-223,252
-55% -$6.78M 2.52% 15
2022
Q1 		$13.3M Buy
407,002
+77,002
+23% +$2.52M 4.14% 9
2021
Q4 		$8.7M Buy
+330,000
New +$8.7M 1.85% 20